Using therapeutic DNA vaccines against mycobacterium TB is a promising strategy, according to a study by Changhong et al. IL-2 and the HSP65 fusion gene expression in DNA vaccines were investigated. The gene discussed is HSPD1; the disease is tuberculosis.